Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration - Williams, AJ; Hale, SL; Moffett, JR (J Cereb Blood Flow Metab, 2003)
et al.